|
|
|
Insider
Information: |
Foley Todd |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
24,224,604 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$103,031,347 |
|
|
Total
Shares |
24,224,604 |
|
|
Total
Value |
$103,031,347 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celladon Corp |
CLDN |
Director |
2014-02-04 |
0 |
2014-02-04 |
1,066,775 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
3,351,048 |
Premium* |
|
Chiasma, Inc |
CHMA |
Director, 10% Owner |
2015-07-21 |
0 |
2015-07-21 |
5,681,544 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
595,436 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2016-09-27 |
0 |
2016-09-27 |
1,427,698 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2017-10-10 |
0 |
2021-03-15 |
909,258 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,524,425 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
Director |
2020-06-23 |
0 |
2021-07-12 |
2,242,636 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2019-12-12 |
4 |
AS |
$25.01 |
$94,088 |
I/I |
(3,762) |
2,393,497 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-25 |
4 |
AS |
$32.87 |
$95,223 |
I/I |
(2,896) |
2,414,551 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-27 |
4 |
AS |
$32.81 |
$115,492 |
I/I |
(3,503) |
2,400,458 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-19 |
4 |
AS |
$15.07 |
$123,574 |
I/I |
(8,200) |
2,362,863 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-08 |
4 |
AS |
$20.05 |
$132,992 |
I/I |
(6,633) |
2,280,211 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-18 |
4 |
AS |
$33.46 |
$133,506 |
I/I |
(3,966) |
2,309,946 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-17 |
4 |
AS |
$15.12 |
$145,953 |
I/I |
(9,653) |
2,383,844 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-20 |
4 |
AS |
$34.66 |
$152,194 |
I/I |
(4,387) |
2,560,588 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-04 |
4 |
AS |
$30.80 |
$173,842 |
I/I |
(5,612) |
2,368,236 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-18 |
4 |
AS |
$15.14 |
$193,504 |
I/I |
(12,781) |
2,371,063 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-27 |
4 |
AS |
$20.13 |
$204,279 |
I/I |
(10,148) |
2,090,299 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-19 |
4 |
AS |
$34.23 |
$205,778 |
I/I |
(5,968) |
2,564,975 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-05-20 |
4 |
AS |
$20.01 |
$210,645 |
I/I |
(10,527) |
2,197,368 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-01 |
4 |
AS |
$20.08 |
$211,543 |
I/I |
(10,535) |
2,060,612 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-01 |
4 |
AS |
$32.50 |
$216,808 |
I/I |
(6,671) |
2,386,410 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-01 |
4 |
AS |
$15.10 |
$233,476 |
I/I |
(15,462) |
2,324,893 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-05-28 |
4 |
AS |
$32.67 |
$241,007 |
I/I |
(7,377) |
2,393,081 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-28 |
4 |
AS |
$34.06 |
$248,521 |
I/I |
(7,270) |
2,271,177 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
10% Owner |
|
2014-03-07 |
4 |
S |
$19.95 |
$250,153 |
I/I |
(12,539) |
0 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-03-31 |
4 |
AS |
$15.16 |
$289,677 |
I/I |
(19,108) |
2,340,355 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-03 |
4 |
AS |
$31.92 |
$313,582 |
I/I |
(9,824) |
2,373,848 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-06-02 |
4 |
AS |
$20.23 |
$315,143 |
I/I |
(15,578) |
2,045,034 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Director |
|
2020-04-28 |
4 |
AS |
$20.07 |
$317,628 |
I/I |
(15,826) |
2,309,067 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-07 |
4 |
AS |
$30.74 |
$332,850 |
I/I |
(10,186) |
2,358,050 |
0 |
- |
|
RPTX |
Repare Therapeutics Inc. |
Director |
|
2021-06-25 |
4 |
AS |
$33.51 |
$333,190 |
I/I |
(9,943) |
2,278,447 |
0 |
- |
|
86 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|